InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.38
(
-0.01%
)
Bitcoin
60,934.93
(
-0.84%
)
Post# of 5006
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BioPharma

Send PM Follow Ignore
Followers 0
Posts 60
Boards Moderated 0
Alias Born 08/14/2016

BioPharma

Re: sabaidii2 post# 3925

Monday, 09/19/2016 10:03:49 PM

Monday, September 19, 2016 10:03:49 PM

Post# of 5006
I agree with you. For scar trials, cohort 1 and 2, the three doses showed improvement 54%, and six doses showed 68% improvement. So for cohort 3 and 4 treated with 9 doses and longer period, do you think the results will be better?

And for Samcyprone with improved composition, and longer treatment, I think the results will be better, Pavco said the first two patients showed very good result with this new improved protocol.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PHIO News
More PHIO News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!